-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Disc Medicine, Raises Price Target to $109

Benzinga·12/16/2025 14:56:02
语音播报
Wells Fargo analyst Derek Archila maintains Disc Medicine (NASDAQ:IRON) with a Overweight and raises the price target from $91 to $109.